alzheimer's disease Archives - Page 4 of 5

Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

Researchers Have Discovered a New Molecular Mechanism in Alzheimer’s Disease

Post author:Kendall Mason
Post published:November 25, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles

At the Tufts University School of Medicine, researchers have uncovered a molecular mechanism that eventually leads to a build-up of amyloid beta, which is a major cause of Alzheimer's disease.…

stevepb / Pixabay

EMA Accepts MAA For Aducanumab, an Alzheimer’s Disease Treatment

Post author:Kendall Mason
Post published:November 12, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles

The European Medicines Agency has accepted Biogen's Marketing Authorization Application (MAA) for review. The application is for aducanumab, a treatment for Alzheimer's disease. As this condition faces an unmet medical…

source: pixabay.com

New Research Will Target Tau’s Role in Alzheimer’s Disease

Post author:Kendall Mason
Post published:November 9, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles Rare Disease

Researchers from Rensselaer Polytechnic Institute have been conducting research on tau proteins, specifically how it spreads from cell to cell. According to an article in Newswise, this team of researchers…

PublicDomainPictures / Pixabay

Could TKIs Be Effective for Patients with Alzheimer’s, Parkinson’s, and Dementia?

Post author:Jessica Lynn
Post published:November 6, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles Parkinson's Disease Rare Disease

What sort of treatments are available for patients with dementia and other neurodegenerative conditions? Are these treatments safe and effective? While these questions vary in answers, researchers are currently exploring…

kfuhlert / Pixabay

New Vaccine Aims to Halt Alzheimer’s Disease Progression

Post author:Kendall Mason
Post published:November 4, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles Rare Disease

Medical professionals are constantly looking for treatments that will halt or even reverse the progression of Alzheimer's disease, and a new vaccine called E22W42 may be a large step in…

source: pixabay.com

First Patient with Alzheimer’s Dosed in Bryostatin-1 Clinical Trial

Post author:Jessica Lynn
Post published:October 15, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles

Last week, clinical stage biopharmaceutical company Neurotrope announced that the first patient was dosed in a Phase 2 clinical trial to test the safety, efficacy, and tolerability of bryostatin-1…

source: pixabay.com

Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases

Post author:Rose Duesterwald
Post published:September 24, 2020
Post category:Alzheimer disease type 3 Alzheimer's disease without Neurofibrillary tangles Parkinson's Disease

According to a recent article in Business Wire, it is estimated that five million people in the United States over the age of sixty-five are coping with Alzheimer’s at…

Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases

Post author:Rose Duesterwald
Post published:September 11, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles Amyotrophic Lateral Sclerosis Progressive Supranuclear Palsy Rare Disease

According to a recent article in MedicalXpress, researchers in Japan led by Dr. Shinsuke Ishigaki and his team at Nagoya University, have identified new molecular details about tau’s activity. Alzheimer’s,…

Source: Pixabay.com

Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

Post author:Jessica Lynn
Post published:September 4, 2020
Post category:Amyotrophic Lateral Sclerosis Multiple Sclerosis

Within the last month, BrainStorm Cell Therapeutics Inc. announced the publication of pre-clinical data on the NurOwn system. NurOwn technology produces autologous, bone marrow-derived mesenchymal stem cells (MSCs) for…

Grant Goes to Elixiron Immunotherapeutics for Alzheimer’s Disease Treatment

Post author:Kendall Mason
Post published:September 2, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles Rare Disease

According to an article from Newswire, the Alzheimer's Association is awarding Elixiron Immunotherapeutics one million dollars for work on their Alzheimer's treatment, EI1071. This money will go towards a clinical…

source: pixabay.com

ICYMI: A New Y-Maze Test Shows Promise for Testing Neurological and Memory Disorders

Post author:Rose Duesterwald
Post published:August 14, 2020
Post category:Rare Disease

Researchers created a new free-movement pattern (FMP) Y-maze from a Y-maze behavioral test that already exists. They believe the test will be effective in people and in animal models. Their…

source: pixabay.com

New Blood Test Improves Alzheimer’s Disease Diagnosis

Post author:Rose Duesterwald
Post published:August 7, 2020
Post category:Alzheimer disease type 3 Alzheimer's disease without Neurofibrillary tangles

A blood test that gives a more accurate diagnosis of Alzheimer’s disease was announced at the July 2020 International Conference of the Alzheimer’s Association. The Association estimates that approximately…

source: pixabay.com

Analyzing the Alzheimer’s Disease Proteome Develops New Drug Targets

Post author:Jessica Lynn
Post published:July 31, 2020
Post category:Alzheimer disease type 3 Alzheimer's disease without Neurofibrillary tangles Progressive Supranuclear Palsy

As of right now, there are no treatments for Alzheimer's disease, a progressive neurodegenerative disorder. However, that may soon change. A study led by UCLA researchers identified potential drug…

source: pixabay.com

Researchers’ Attention is Shifting to a New Theory About Alzheimer’s Disease

Post author:Rose Duesterwald
Post published:July 21, 2020
Post category:Alzheimer disease type 3 Alzheimer's disease without Neurofibrillary tangles

According to a recent article in BioSpace, Biogen and Eisai have launched a new preclinical Phase III trial of BAN2401 to treat pre-clinical Alzheimer's disease. The new study follows…

source: pixabay.com

Planned Phase 2 Trial of ANVS401 for Alzheimer’s and Parkinson’s Moving Forward

Post author:Sunniva Bean
Post published:July 20, 2020
Post category:Alzheimer disease type 3 Alzheimer's disease without Neurofibrillary tangles Parkinson's Disease

As reported in Parkinson's News Today, an investigational therapy to treat patients with Alzheimer's disease and Parkinson’s disease has had its Phase 2 trial approved by the central institutional review…

source: pixabay.com

Biomarkers in Alzheimer’s Give Researchers a Heads Up to Predict Early Parkinson’s Disease

Post author:Rose Duesterwald
Post published:July 8, 2020
Post category:Alzheimer disease type 3 Alzheimer's disease without Neurofibrillary tangles Parkinson's Disease

Parkinson’s News Today recently published an article containing new information about biomarkers in Alzheimer’s disease that can be linked to the early stages of Parkinson’s disease. Many people with…

Image by Markus Spiske from Pixabay

Scientists Can Identify Schwann Cells Using Novel Bar Code Technique

Post author:Jessica Lynn
Post published:July 3, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles Amyotrophic Lateral Sclerosis Rare Disease Spinal Muscular Atrophy

Scientists and researchers have long known how important glial cells are to the nervous system. Not only do these cells make up a majority of cells within the central nervous…

GerryShaw / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

How Rogue Astrocytes Cause Neurodegeneration

Post author:Jessica Lynn
Post published:June 22, 2020
Post category:Multiple Sclerosis Parkinson's Disease

You have a number of different cells throughout your body, all of which perform different functions or provide support. One extremely interesting type are astrocytes, star-shaped glial cells that…

source: pixabay.com

New Study to Evaluate Alzheimer’s Disease Treatment

Post author:Kendall Mason
Post published:June 3, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles

Neurotrope is launching a long term Phase 2 trial of Bryostatin-1, which is a treatment for Alzheimer's disease. The National Institutes of Health (NIH) will be joining this study, giving…

source: pixabay.com

Study: ANAVEX 3-71 as a Treatment for Neurodegenerative Diseases

Post author:Kendall Mason
Post published:June 1, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles Parkinson's Disease Rett Syndrome

Anavex Life Sciences Corporation has recently announced that they will conduct a clinical trial for their small molecule, ANAVEX®3-71. This therapy is intended to treat neurodegenerative and neurodevelopmental conditions, such…

HSV-1 Linked to Alzheimer’s Disease in Mini-Brain Study

Post author:Jessica Lynn
Post published:May 12, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles

According to News Scientist, researchers from Tufts University recently sought to understand whether Alzheimer's disease could result from viral causes. They focused on herpes simplex virus 1 (HSV-1), a common…

Researchers Add a Third Risk Factor To Alzheimer’s Disease That Affects the Blood Brain Barrier

Post author:Rose Duesterwald
Post published:May 8, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles Rare Disease

It is acknowledged in the medical community that clumps of misfolded tau proteins and amyloid-β are markers of Alzheimer’s disease. The evidence presented in recent article in Nature, shows that…

5239640 / Pixabay

Caring for Someone with Alzheimer’s Disease During COVID-19

Post author:Jessica Lynn
Post published:April 24, 2020
Post category:Alzheimer disease type 3 Alzheimer's disease without Neurofibrillary tangles Rare Disease

COVID-19 is difficult for many of us. We are facing an unprecedented time and questions abound. How do we handle our work, our families, our health? If you are a…

source: pixabay.com

Klotho Gene Variant Reduces Alzheimer’s Disease Risk in High-Risk Adults

Post author:Jessica Lynn
Post published:April 23, 2020
Post category:Alzheimer's disease without Neurofibrillary tangles

According to MedPage Today, carriers of the gene variation APOE4 are much more at risk of developing Alzheimer's disease. However, researchers found that one copy of the Klotho gene mutation,…

Free-Photos / Pixabay

Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease

Post author:Jessica Lynn
Post published:April 17, 2020
Post category:Alzheimer disease type 3 Rare Disease

According to an article in The Asahi Shimbun, Japanese scientists have developed a new vaccine to mitigate neuronal degeneration caused by Alzheimer's disease. The vaccine, delivered nasally, had promising results…

Researchers Have Discovered a New Molecular Mechanism in Alzheimer’s Disease

EMA Accepts MAA For Aducanumab, an Alzheimer’s Disease Treatment

New Research Will Target Tau’s Role in Alzheimer’s Disease

Could TKIs Be Effective for Patients with Alzheimer’s, Parkinson’s, and Dementia?

New Vaccine Aims to Halt Alzheimer’s Disease Progression

First Patient with Alzheimer’s Dosed in Bryostatin-1 Clinical Trial

Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases

Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases

Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

Grant Goes to Elixiron Immunotherapeutics for Alzheimer’s Disease Treatment

ICYMI: A New Y-Maze Test Shows Promise for Testing Neurological and Memory Disorders

New Blood Test Improves Alzheimer’s Disease Diagnosis

Analyzing the Alzheimer’s Disease Proteome Develops New Drug Targets

Researchers’ Attention is Shifting to a New Theory About Alzheimer’s Disease

Planned Phase 2 Trial of ANVS401 for Alzheimer’s and Parkinson’s Moving Forward

Biomarkers in Alzheimer’s Give Researchers a Heads Up to Predict Early Parkinson’s Disease

Scientists Can Identify Schwann Cells Using Novel Bar Code Technique

How Rogue Astrocytes Cause Neurodegeneration

New Study to Evaluate Alzheimer’s Disease Treatment

Study: ANAVEX 3-71 as a Treatment for Neurodegenerative Diseases

HSV-1 Linked to Alzheimer’s Disease in Mini-Brain Study

Researchers Add a Third Risk Factor To Alzheimer’s Disease That Affects the Blood Brain Barrier

Caring for Someone with Alzheimer’s Disease During COVID-19

Klotho Gene Variant Reduces Alzheimer’s Disease Risk in High-Risk Adults

Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

“Shades of Psoriasis”: Plaque Psoriasis and Sharing Your Story

Understanding RSV: Why Combatting Ethnic and Age-Related Health Disparities Could Improve Outcomes

We Need Equity and Diversity Within Rare Disease Research

DNA in Color: How Ronya Nelson is Working to Close the Diversity Gap in Genetics - Part 1

Bridging the Diversity Gap in Healthcare

Congratulations to the 2023 Recipients of the Diversity in Lupus Research Awards!

Welcome to Study of the Week. We go in-depth and select a study we think is of particular interest, discussing details, explaining its importance, who may be impacted and lots more!

Let’s Work Together!

Keep Up to Date

Learn More